Primary leukocyte screens for innate immune agonists

Journal of Biomolecular Screening

Volumn 14, Issue 6, 2009, Pages 723-730

  Goodchild, Amber ^a   Nopper, Nicole ^a   Craddock, Alexis ^a   Law, Tamara ^a,c   King, Andrew ^a   Fanning, Gregory ^b   Rivory, Laurent ^a   Passioura, Toby ^a  

^a JOHNSON AND JOHNSON   (United States)

^b Tibotec Pharmaceuticals   (Ireland)

^c CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

Author keywords

High throughput screening; Immunostimulants; Innate immune agonists; Toll like receptors

Indexed keywords

CL 097; GARDIQUIMOD; IMIQUIMOD; IMMUNOSTIMULATING AGENT; INTERFERON; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE ACTIVATION; MAMMAL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR GENE; REPLICON; SENSITIVITY AND SPECIFICITY; TLR GENE; VIRUS INHIBITION;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; CELL COUNT; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DENDRITIC CELLS; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; NUCLEIC ACIDS; TOLL-LIKE RECEPTORS;

HEPATITIS C VIRUS; MAMMALIA;

EID: 67651021180     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057109335325     Document Type: Article

References (14)

1. Gantier MP, Williams BR: The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev 2007 ; 18: 363-371.
2. Akira S., Takeda K.: Toll-like receptor signalling. Nat Rev Immunol 2004 ; 4: 499-511.
3. Alexopoulou L., Holt AC, Medzhitov R., Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001 ; 413: 732-738.
4. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 ; 408: 740-745.
5. Thomas A., Laxton C., Rodman J., Myangar N., Horscroft N., Parkinson T.: Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection. Antimicrob Agents Chemother 2007 ; 51: 2969-1978.
6. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003 ; 171: 3154-3162.
7. Sioud M.: Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 2005 ; 348: 1079-1090.
8. Judge AD, Sood V., Shaw JR, Fang D., McClintock K., MacLachlan I.: Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005 ; 23: 457-462.
9. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002 ; 168: 4531-4537.
10. Lee J., Chuang TH, Redecke V., She L., Pitha PM, Carson DA, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 2003 ; 100: 6646-6651.
11. Buckner D., Wilson S., Kurk S., Hardy M., Miessner N., Jutila MA: Use of early passage fetal intestinal epithelial cells in semi-high-throughput screening assays: an approach to identify new innate immune system adjuvants. J Biomol Screen 2006 ; 11: 664-671.
12. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004 ; 303: 1526-1529.
13. Inglefield JR, Larson CJ, Gibson SJ, Lebrec H., Miller RL: Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry. J Biomol Screen 2006 ; 11: 575-585.
14. Vrolijk JM, Kaul A., Hansen BE, Lohmann V., Haagmans BL, Schalm SW, et al. A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. J Virol Methods 2003 ; 110: 201-209.